[Science] Japan Approves First-Ever 'Biosimilar' Drug


	[Science] Japan Approves First-Ever 'Biosimilar' Drug

Laxon

6-25-2009 5:09 PM

69 views

tags:

reclip, novartis

Laxon says:

Interesting, but not as exciting as it would have been a few years ago.

Add a Comment

Login to Comment. Not a member yet? Sign up

Today's Top Clips

visit the Top Clips page

View the Top Clips from June 25, 2009

Embed This Clip In Your Site...

<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/812f4b51-de79-49f1-8962-bf3988c420cd/CDEE2992-6719-4C78-B8A6-19188DDBE35A/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.redorbit.com/news/health/1711779/japan_approves_firstever_biosimilar_drug/index.html?source=r_health" href="http://www.redorbit.com/news/health/1711779/japan_approves_firstever_biosimilar_drug/index.html?source=r_health" style="font-size: 11px;">www.redorbit.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.redorbit.com/news/health/1711779/japan_approves_firstever_biosimilar_drug/index.html?source=r_health"><div align="center"><img src="http://content7.clipmarks.com/blog_cache/www.redorbit.com/img/8482285B-0911-4FA3-B431-168E3AD23EB2" alt="" /></div></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.redorbit.com/news/health/1711779/japan_approves_firstever_biosimilar_drug/index.html?source=r_health"><P>Regulators in Japan on Thursday approved the first-ever generic of a biotech drug.</P><P>The decision is likely to pave the way “for greater access to high-quality biopharmaceuticals in Japan,” according to Sandoz, Novartis AG’s generics group.</P><P>Sandoz’ Somatropin injection is used for the treatment of growth hormone deficiency in children as well as growth disruption caused by Turner’s syndrome or chronic renal insufficiency, the company said. The drug is being offered as an alternative to Pfizer’s Genotropin.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.redorbit.com/news/health/1711779/japan_approves_firstever_biosimilar_drug/index.html?source=r_health"><P>“Together with our parent company Novartis, we are fully committed to broadening access to innovative and affordable biopharmaceuticals over the years and decades to come, both in Japan and worldwide," said Jeff George, Chief Executive of Sandoz.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.redorbit.com/news/health/1711779/japan_approves_firstever_biosimilar_drug/index.html?source=r_health"><P>The approval marks the first-ever biosimilar drug to be approved in Japan.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.redorbit.com/news/health/1711779/japan_approves_firstever_biosimilar_drug/index.html?source=r_health"><P>Stefan Borgas, chief executive of drug supplier Lonza Group Ltd, told Reuters that he expects biotech drugs to become a “significant market.”</P></blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/CDEE2992-6719-4C78-B8A6-19188DDBE35A/blog/" title="blog or email this clip"><img src="http://content8.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks: Amplify.com - Don't just share the news...Amplify it!

Clipmarks: Home; New Clips; Top Clips; Dashboard

Popular Topics: News; Life; Science; Technology; Entertainment

Get Started: Sign Up; Install Clipping Tool; How Clipping Works; Clip-to-Blog™; ClipSearch

Tools and Resources: FAQ; ClipWeek; Top Clippers; Top Tags; Site Map

About Clipmarks: About Us; Contact; Copyright; Privacy; EULA

Search Options

Today's Top Clips